Africa (WHO region) vs Egypt: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Africa (WHO region)
89.0%
in 2014
Egypt
100.0%
in 2014
Africa (WHO region) rank
2nd
Egypt rank
1st
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Africa (WHO region)
- Egypt
How they compare
Egypt currently reports 100.0% against 89.0% in Africa (WHO region), a difference of 11.0%.
That makes Egypt's figure about 1.1 times Africa (WHO region)'s.
Across all 9 years both countries report, Egypt has been ahead every year.
Africa (WHO region) ranks 2nd and Egypt ranks 1st of 11 groups.
Egypt has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 77.5% | 100.0% | 22.5% | Egypt |
| 2010s | 85.0% | 100.0% | 15.0% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Africa (WHO region) or Egypt?
- Egypt, at 100.0% against 89.0% in Africa (WHO region) as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Africa (WHO region) and Egypt?
- 11.0%, with Egypt ahead.
- How many years of comparable data are there for Africa (WHO region) and Egypt?
- 9 years are reported by both, from 2006 to 2014.
- How do Africa (WHO region) and Egypt rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Africa (WHO region) ranks 2nd and Egypt ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.